Assessment of adherence to the guidelines for the management of nausea and vomiting induced by chemotherapy

Detalhes bibliográficos
Autor(a) principal: França,Monique Sedlmaier
Data de Publicação: 2015
Outros Autores: Usón Junior,Pedro Luiz Serrano, Antunes,Yuri Philippe Pimentel Vieira, Prado,Bernard Lobato, Donnarumma,Carlos del Cistia, Mutão,Taciana Sousa, Rodrigues,Heloisa Veasey, Giglio,Auro del
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Einstein (São Paulo)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082015000200009
Resumo: ABSTRACT Objective: To assess adherence of the prescribing physicians in a private cancer care center to the American Society of Clinical Oncology guideline for antiemetic prophylaxis, in the first cycle of antineoplastic chemotherapy. Methods: A total of 139 chemotherapy regimens, of 105 patients, were evaluated retrospectively from 2011 to 2013. Results: We observed 78% of non-adherence to the guideline rate. The main disagreements with the directive were the prescription of higher doses of dexamethasone and excessive use of 5-HT3 antagonist for low risk emetogenic chemotherapy regimens. On univariate analysis, hematological malignancies (p=0.005), the use of two or more chemotherapy (p=0.05) and high emetogenic risk regimes (p=0.012) were factors statistically associated with greater adherence to guidelines. Treatment based on paclitaxel was the only significant risk factor for non-adherence (p=0.02). By multivariate analysis, the chemotherapy of high emetogenic risk most correlated with adherence to guideline (p=0.05). Conclusion: We concluded that the adherence to guidelines is greater if the chemotherapy regime has high emetogenic risk. Educational efforts should focus more intensely on the management of chemotherapy regimens with low and moderate emetogenic potential. Perhaps the development of a computer generated reminder may improve the adherence to guidelines.
id IIEPAE-1_c24ab63533149f9d447018968cf8e896
oai_identifier_str oai:scielo:S1679-45082015000200009
network_acronym_str IIEPAE-1
network_name_str Einstein (São Paulo)
repository_id_str
spelling Assessment of adherence to the guidelines for the management of nausea and vomiting induced by chemotherapyNausea/chemically inducedVomiting/chemically inducedClinical protocolsAdvance directive adherenceDrug therapy/adverse effectsAntiemeticsABSTRACT Objective: To assess adherence of the prescribing physicians in a private cancer care center to the American Society of Clinical Oncology guideline for antiemetic prophylaxis, in the first cycle of antineoplastic chemotherapy. Methods: A total of 139 chemotherapy regimens, of 105 patients, were evaluated retrospectively from 2011 to 2013. Results: We observed 78% of non-adherence to the guideline rate. The main disagreements with the directive were the prescription of higher doses of dexamethasone and excessive use of 5-HT3 antagonist for low risk emetogenic chemotherapy regimens. On univariate analysis, hematological malignancies (p=0.005), the use of two or more chemotherapy (p=0.05) and high emetogenic risk regimes (p=0.012) were factors statistically associated with greater adherence to guidelines. Treatment based on paclitaxel was the only significant risk factor for non-adherence (p=0.02). By multivariate analysis, the chemotherapy of high emetogenic risk most correlated with adherence to guideline (p=0.05). Conclusion: We concluded that the adherence to guidelines is greater if the chemotherapy regime has high emetogenic risk. Educational efforts should focus more intensely on the management of chemotherapy regimens with low and moderate emetogenic potential. Perhaps the development of a computer generated reminder may improve the adherence to guidelines.Instituto Israelita de Ensino e Pesquisa Albert Einstein2015-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082015000200009einstein (São Paulo) v.13 n.2 2015reponame:Einstein (São Paulo)instname:Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE)instacron:IIEPAE10.1590/S1679-45082015AO3097info:eu-repo/semantics/openAccessFrança,Monique SedlmaierUsón Junior,Pedro Luiz SerranoAntunes,Yuri Philippe Pimentel VieiraPrado,Bernard LobatoDonnarumma,Carlos del CistiaMutão,Taciana SousaRodrigues,Heloisa VeaseyGiglio,Auro deleng2015-12-03T00:00:00Zoai:scielo:S1679-45082015000200009Revistahttps://journal.einstein.br/pt-br/ONGhttps://old.scielo.br/oai/scielo-oai.php||revista@einstein.br2317-63851679-4508opendoar:2015-12-03T00:00Einstein (São Paulo) - Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE)false
dc.title.none.fl_str_mv Assessment of adherence to the guidelines for the management of nausea and vomiting induced by chemotherapy
title Assessment of adherence to the guidelines for the management of nausea and vomiting induced by chemotherapy
spellingShingle Assessment of adherence to the guidelines for the management of nausea and vomiting induced by chemotherapy
França,Monique Sedlmaier
Nausea/chemically induced
Vomiting/chemically induced
Clinical protocols
Advance directive adherence
Drug therapy/adverse effects
Antiemetics
title_short Assessment of adherence to the guidelines for the management of nausea and vomiting induced by chemotherapy
title_full Assessment of adherence to the guidelines for the management of nausea and vomiting induced by chemotherapy
title_fullStr Assessment of adherence to the guidelines for the management of nausea and vomiting induced by chemotherapy
title_full_unstemmed Assessment of adherence to the guidelines for the management of nausea and vomiting induced by chemotherapy
title_sort Assessment of adherence to the guidelines for the management of nausea and vomiting induced by chemotherapy
author França,Monique Sedlmaier
author_facet França,Monique Sedlmaier
Usón Junior,Pedro Luiz Serrano
Antunes,Yuri Philippe Pimentel Vieira
Prado,Bernard Lobato
Donnarumma,Carlos del Cistia
Mutão,Taciana Sousa
Rodrigues,Heloisa Veasey
Giglio,Auro del
author_role author
author2 Usón Junior,Pedro Luiz Serrano
Antunes,Yuri Philippe Pimentel Vieira
Prado,Bernard Lobato
Donnarumma,Carlos del Cistia
Mutão,Taciana Sousa
Rodrigues,Heloisa Veasey
Giglio,Auro del
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv França,Monique Sedlmaier
Usón Junior,Pedro Luiz Serrano
Antunes,Yuri Philippe Pimentel Vieira
Prado,Bernard Lobato
Donnarumma,Carlos del Cistia
Mutão,Taciana Sousa
Rodrigues,Heloisa Veasey
Giglio,Auro del
dc.subject.por.fl_str_mv Nausea/chemically induced
Vomiting/chemically induced
Clinical protocols
Advance directive adherence
Drug therapy/adverse effects
Antiemetics
topic Nausea/chemically induced
Vomiting/chemically induced
Clinical protocols
Advance directive adherence
Drug therapy/adverse effects
Antiemetics
description ABSTRACT Objective: To assess adherence of the prescribing physicians in a private cancer care center to the American Society of Clinical Oncology guideline for antiemetic prophylaxis, in the first cycle of antineoplastic chemotherapy. Methods: A total of 139 chemotherapy regimens, of 105 patients, were evaluated retrospectively from 2011 to 2013. Results: We observed 78% of non-adherence to the guideline rate. The main disagreements with the directive were the prescription of higher doses of dexamethasone and excessive use of 5-HT3 antagonist for low risk emetogenic chemotherapy regimens. On univariate analysis, hematological malignancies (p=0.005), the use of two or more chemotherapy (p=0.05) and high emetogenic risk regimes (p=0.012) were factors statistically associated with greater adherence to guidelines. Treatment based on paclitaxel was the only significant risk factor for non-adherence (p=0.02). By multivariate analysis, the chemotherapy of high emetogenic risk most correlated with adherence to guideline (p=0.05). Conclusion: We concluded that the adherence to guidelines is greater if the chemotherapy regime has high emetogenic risk. Educational efforts should focus more intensely on the management of chemotherapy regimens with low and moderate emetogenic potential. Perhaps the development of a computer generated reminder may improve the adherence to guidelines.
publishDate 2015
dc.date.none.fl_str_mv 2015-06-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082015000200009
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082015000200009
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S1679-45082015AO3097
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Instituto Israelita de Ensino e Pesquisa Albert Einstein
publisher.none.fl_str_mv Instituto Israelita de Ensino e Pesquisa Albert Einstein
dc.source.none.fl_str_mv einstein (São Paulo) v.13 n.2 2015
reponame:Einstein (São Paulo)
instname:Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE)
instacron:IIEPAE
instname_str Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE)
instacron_str IIEPAE
institution IIEPAE
reponame_str Einstein (São Paulo)
collection Einstein (São Paulo)
repository.name.fl_str_mv Einstein (São Paulo) - Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE)
repository.mail.fl_str_mv ||revista@einstein.br
_version_ 1752129907885867008